Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

More than one in 10 Americans use antidepressants
Reuters
Thursday, October 20, 2011 - 9:22am
tags:
antidepressants
Cubist says 3Q profit falls, but raises outlook
Yahoo/AP
Thursday, October 20, 2011 - 9:21am
tags:
earnings, Cubist
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Bloomberg
Thursday, October 20, 2011 - 9:17am
tags:
Biogen Idec, FDA, Elan, Tysabri, MS, multiple sclerosis
Amgen To Lay Off Nearly 400 Employees
Pharmalot
Thursday, October 20, 2011 - 9:09am
tags:
Amgen, layoffs
Lilly-Amylin’s Diabetes Drug Wins Approval for Expanded Use
Bloomberg
Thursday, October 20, 2011 - 9:04am
tags:
Eli Lilly, Amylin, Byetta, diabetes
Abbott Labs Spinoff May Fetch $54 Billion
Bloomberg
Thursday, October 20, 2011 - 9:01am
tags:
Abbott Laboratories, reorganization, spinoff
Eli Lilly Q3 net profit drops 5%; sales rise 9%
Marketwatch
Thursday, October 20, 2011 - 9:00am
tags:
earnings, Eli Lilly
Abbott Breakup Follows Familiar Pattern
Seeking Alpha
Thursday, October 20, 2011 - 8:56am
tags:
Abbott Laboratories, reorganization, JNJ, Eli Lilly
SAC Faces SEC Probe Into Johnson & Johnson Cougar Move, WSJ Says
Bloomberg
Thursday, October 20, 2011 - 8:54am
tags:
SAC, SEC, JNJ, M&A, Cougar Biotechnology
Abbott earmarks $1.5B for off-label Depakote settlement
Fierce Pharma
Wednesday, October 19, 2011 - 5:41pm
tags:
Abbott Laboratories, Depakote, settlements, off-label
Jazz Pharma's stock plunges, following FDA warning
Bizjournals.com
Wednesday, October 19, 2011 - 5:40pm
tags:
Jazz Pharmaceuticals, warnings, FDA, Xyrem
Earnings Preview: Amgen
Forbes
Wednesday, October 19, 2011 - 5:38pm
tags:
Amgen, earnings
Pressure grows on drugmakers to reveal R&D returns
Reuters
Wednesday, October 19, 2011 - 5:36pm
tags:
R&D
J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
FT.com
Wednesday, October 19, 2011 - 12:04pm
tags:
JNJ, drug shortages, Doxil, Caelyx, ovarian cancer
Takeda starts Phase III trials of first-in-class diabetes drug
Pharma Times, UK
Wednesday, October 19, 2011 - 12:02pm
tags:
Takeda, diabetes, TAK-875
Halozyme Buoyed By Good Herceptin News
Seeking Alpha
Wednesday, October 19, 2011 - 10:48am
tags:
Herceptin, Halozyme, breast cancer
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year
Xconomy
Wednesday, October 19, 2011 - 10:39am
tags:
Vertex, FDA, cystic fibrosis, ivacaftor, Kalydeco, VX-770
Merck Settles Shareholder Suit Over Enhance Trial
Pharmalot
Wednesday, October 19, 2011 - 10:38am
tags:
Merck, ENHANCE, Vytorin, shareholders, settlements, Schering Plough
Mylan settles lawsuit with Warner Chilcott
Bizjournals.com
Wednesday, October 19, 2011 - 10:37am
tags:
Warner Chilcott, Mylan, Femcon FE, birth control pill, generics
Keryx: Readers React to Perifosine Prediction
TheStreet.com
Wednesday, October 19, 2011 - 9:41am
tags:
Keryx, Perifisone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.